Literature DB >> 34001792

Multisystem Inflammatory Syndrome in a Pediatric Patient With Sickle Cell Disease and COVID-19: A Case Report.

María G Español1, Renee V Gardner1, Minelys M Alicea-Marrero1, Gisela Marrero-Rivera1, Tamara Bradford2, Dana M LeBlanc1, María C Velez1.   

Abstract

To this day, there are limited data about the effects and management of coronavirus disease infection in pediatric patients with sickle cell disease. We present the management and successful clinical course of an 8-year-old female with homozygous sickle cell disease (SS) and severe acute chest syndrome secondary to coronavirus disease 2019 infection, complicated by cortical vein thrombosis.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 34001792     DOI: 10.1097/MPH.0000000000002191

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  2 in total

Review 1.  Clinical outcomes of COVID-19 in patients with sickle cell disease and sickle cell trait: A critical appraisal of the literature.

Authors:  Wouter S Hoogenboom; Tharun T Alamuri; Daniel M McMahon; Nino Balanchivadze; Vrushali Dabak; William B Mitchell; Kerry B Morrone; Deepa Manwani; Tim Q Duong
Journal:  Blood Rev       Date:  2021-11-20       Impact factor: 10.626

2.  Multisystem Inflammatory Syndrome in a Previously Vaccinated Adolescent Female With Sickle Cell Disease.

Authors:  Joshua DeJong; Rebecca Sainato; Melissa Forouhar; David Robinson; Anjali Kunz
Journal:  Pediatr Infect Dis J       Date:  2022-03-01       Impact factor: 2.129

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.